Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 2021

View Archived Issues

IL-36-gamma is a marker of enthesitis-related arthritis

Preclinical data presented on INBRX-121 as monotherapy or in combination with IO therapy regimens

Novel pan-ERR agonists can provide cardioprotection against heart failure

Plexin D1-positive extracellular vesicles as potential biomarker of polymyositis and dermatomyositis

Increased BMP-10 activity tied to disease severity in pulmonary hypertension

Assembly Biosciences patents new compounds for HBV

Chinese researchers divulge GTPase KRAS mutant inhibitors

IMMvention Therapeutix synthesizes NLRP3 inflammasome inhibitors

Shenzhen Jingtai Technology discloses new Ret inhibitors

Accutar Biotechnology describes new compounds for cancer

Promising in vivo PK and toxicity data presented for GS-3583

U.K. study illuminates value of whole genome sequencing in rare disease care

BetterLife reports first behavioral animal pharmacology data on TD-0148A

Pyramid licenses rights to MPS1 inhibitor VRN-08 from Voronoi

Researchers unveil CCN1 as a therapeutic target for rheumatoid arthritis

CRV-431 significantly decreases growth of liver tumors in mouse model of liver cancer

New mouse model allows assessment of HTT mRNA targeting compounds for Huntington's disease

Novoron secures funding to support development of NOVO-118 for spinal cord injury and MS

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...